Opiant Pharmaceuticals
Indivior is a global pharmaceutical company focused on developing treatments for substance use disorders and serious mental illnesses, with products available in 37 countries.
History
Indivior is a global pharmaceutical company headquartered in North Chesterfield, Virginia. The company has been pioneering life-transforming treatments for substance use disorders and serious mental illnesses. Over the years, Indivior has focused on creating and improving treatment options for opioid use disorder and conditions like schizophrenia. The company has expanded its presence significantly, with its portfolio of products available in 37 countries.
Therapeutic Focus Areas
Indivior focuses on creating and developing treatments for opioid use disorder and serious mental illnesses, such as schizophrenia. They have developed four buprenorphine-based medications specifically designed to treat opioid use disorder. Indivior also offers a monthly treatment option for schizophrenia in adult patients. Their pipeline extends to the development of treatments for cannabis use disorder, alcohol use disorder, and acute cannabinoid overdose.
Products
Indivior's product line includes SUBLOCADE® (buprenorphine extended-release) injection, which addresses opioid use disorder, and PERSERIS® (risperidone) for extended-release injectable suspension for the treatment of schizophrenia. The company has also developed a range of daily and monthly treatment options for patients with moderate-to-severe opioid use disorder. Their products undergo strict regulatory guidelines and quality standards to ensure safety and efficacy.
Research and Development
Indivior's R&D efforts have led to several significant developments in addiction medicine. They have established exclusive global license agreements with Alar Pharmaceuticals, Inc. for INDV-6001, a sustained-release LAI prodrug of buprenorphine, and with Addex Pharma S.A. for INDV-1000, a Gamma-aminobutyric acid subtype B (GABAB) positive allosteric modulator (PAM). These collaborations demonstrate Indivior's commitment to advancing treatment options for substance use disorders.
Sustainability and Governance
Indivior's sustainability framework centers on five key pillars: transforming patient lives, prioritizing people, conducting business with integrity, addressing environmental responsibilities, and providing products. They have a comprehensive sustainability governance structure involving strategy and policies, management systems and processes, performance measurement and monitoring, and stakeholder engagement. The Sustainability Committee, comprising all members of the Executive Committee, oversees ESG strategy implementation. Additionally, Indivior's Integrity & Compliance Program ensures adherence to applicable laws and regulations through written policies, training, communication, auditing, monitoring, and enforcement.